Clinical Trial Update: Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the safety and tolerability of lixisenatide as monotherapy in adults with type 2 diabetes has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lixisenatide (lixisenatide)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED